These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2219385

  • 21. Quality of life on cyclosporine versus conventional therapy.
    Simmons RG, Abress LK.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
    [No Abstract] [Full Text] [Related]

  • 22. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 23. [Kidney transplantation: the end of classical immunosuppression with azathioprine?].
    Gonnermann D, Huland H, Kraemer-Hansen H, Klosterhalfen H.
    Dtsch Med Wochenschr; 1984 Nov 02; 109(44):1689-91. PubMed ID: 6386420
    [No Abstract] [Full Text] [Related]

  • 24. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

  • 25. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS, Samhan M, John P, al-Adnani MS, Abouna GM.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract] [Full Text] [Related]

  • 26. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ, Harding ME, deVeber GA, Honey J, Cook GT.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of chronic kidney allograft rejection by cyclosporine.
    Abbud-Filho M, Ramalho HJ, Barberato JB, Corrente JE, Zerati-Filho M, Verona CB, Martucci RC, Bezas AG.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):1660-2. PubMed ID: 2652544
    [No Abstract] [Full Text] [Related]

  • 28. Urinary tract infection after renal transplantation under conventional therapy and cyclosporine.
    Stuby U, Kaiser W, Grafinger P, Biesenbach G, Zazgornik J.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):2110-1. PubMed ID: 2652680
    [No Abstract] [Full Text] [Related]

  • 29. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS, Reitz BA, Greene PS, Augustine S, Baumgartner WA.
    J Thorac Cardiovasc Surg; 1989 Nov 02; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [Abstract] [Full Text] [Related]

  • 30. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
    Kootte AM, van Dorp WT, van Bockel JH, van Es LA, Paul LC.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):1585-6. PubMed ID: 2652515
    [No Abstract] [Full Text] [Related]

  • 31. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA, Shakuntala V, Dhawan IK, Zahir M, Shanwaz M, Hayes K, Pingle A.
    Transplant Proc; 1993 Jun 02; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract] [Full Text] [Related]

  • 32. Liver disease in renal transplant recipients.
    Sharma RK, Elhence R, Kher V, Naik SR, Bhandari M.
    Transplant Proc; 1992 Oct 02; 24(5):1915. PubMed ID: 1412911
    [No Abstract] [Full Text] [Related]

  • 33. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 34. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
    Oka T, Omori Y, Aikawa I, Yasumura T, Yoshimura N, Nakai I.
    Transplant Proc; 1988 Jun 02; 20(3 Suppl 3):143-6. PubMed ID: 3291229
    [No Abstract] [Full Text] [Related]

  • 35. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH, Van Buren CT, Lewis RM, Kahan BD.
    Transplant Proc; 1988 Jun 02; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract] [Full Text] [Related]

  • 36. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
    Schulak JA, Moritz CE, Hricik DE.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):1709-11. PubMed ID: 2652560
    [No Abstract] [Full Text] [Related]

  • 37. Successful cadaveric renal transplantation in infants and young children.
    Ettenger RB, Rosenthal JT, Marik J, Salusky IB, Kamil E, Malekzadeh MH, Fine RN.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):1707-8. PubMed ID: 2652559
    [No Abstract] [Full Text] [Related]

  • 38. Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
    Boudreaux JP, McHugh L, Canafax DM, Asher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 2):1811-3. PubMed ID: 3079040
    [No Abstract] [Full Text] [Related]

  • 39. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Transplant Proc; 1987 Feb 02; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract] [Full Text] [Related]

  • 40. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM, Griñó JM, Sabaté I, Gilvernet S, Andres E, Sabater R, Alsina J.
    Transplant Proc; 1989 Feb 02; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.